Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis.
about
Tuberculosis and HIV co-infectionDelivery of RNAi Therapeutics to the Airways-From Bench to BedsideSuppression of the NF-κB pathway by diesel exhaust particles impairs human antimycobacterial immunityA network map of Interleukin-10 signaling pathwayDynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.ESAT6-induced IFNgamma and CXCL9 can differentiate severity of tuberculosis.Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis.Association of reduced tumor necrosis factor alpha, gamma interferon, and interleukin-1beta (IL-1beta) but increased IL-10 expression with improved chest radiography in patients with pulmonary tuberculosis.Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice.Expression patterns and action analysis of genes associated with physiological responses during rat liver regeneration: cellular immune response.Changes in serum cytokine levels in active tuberculosis with treatment.Macrophage immunoregulatory pathways in tuberculosis.An antibody against the surfactant protein A (SP-A)-binding domain of the SP-A receptor inhibits T cell-mediated immune responses to Mycobacterium tuberculosis.Coinfection with Cryptococcus gattii and Mycobacterium tuberculosis in an otherwise healthy 18-year-old woman.Rv2468c, a novel Mycobacterium tuberculosis protein that costimulates human CD4+ T cells through VLA-5.Evaluation of interleukin-10 levels in the plasma of patients with various stages of tuberculosis.Enhancement of the sensitivity of the whole-blood gamma interferon assay for diagnosis of Mycobacterium bovis infections in cattle.Tuberculosis is associated with expansion of a motile, permissive and immunomodulatory CD16(+) monocyte population via the IL-10/STAT3 axis.IL-10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection.Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.Differential expression of interleukin-4 (IL-4) and IL-4 delta 2 mRNA, but not transforming growth factor beta (TGF-beta), TGF-beta RII, Foxp3, gamma interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis treThe immuno-endocrine component in the pathogenesis of tuberculosis.Interleukin-10 and interferon-gamma patterns during tuberculosis treatment: possible association with recurrence.Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts.Interleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophagesInterleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J miceSpotlight on Mycobacteria and dendritic cells: will novel targets to fight tuberculosis emerge?Pleural fluid from tuberculous pleurisy inhibits the functions of T cells and the differentiation of Th1 cells via immunosuppressive factors.The role of IL-10 in immune regulation during M. tuberculosis infection.Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.Integrating knowledge of Mycobacterium tuberculosis pathogenesis for the design of better vaccines.T Cell-Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection.Understanding the pathophysiology of the human TB lung granuloma using in vitro granuloma models.Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guérin.Bystander macrophage apoptosis after Mycobacterium tuberculosis H37Ra infection.TUBERCULOSIS INFECTION MIGHT INCREASE THE RISK OF INVASIVE CANDIDIASIS IN AN IMMUNOCOMPETENT PATIENT.Inhibition of Mycobacterium tuberculosis-induced signalling by transforming growth factor-β in human mononuclear phagocytes.Development of a novel PCR restriction analysis of the hsp65 gene as a rapid method to screen for the Mycobacterium tuberculosis complex and nontuberculous mycobacteria in high-burden countries.IL-37 Expression is Upregulated in Patients with Tuberculosis and Induces Macrophages Towards an M2-like Phenotype.Computational modeling predicts IL-10 control of lesion sterilization by balancing early host immunity-mediated antimicrobial responses with caseation during mycobacterium tuberculosis infection
P2860
Q21131403-B8DF3AC3-CB2B-462F-AEEA-CFCF87E44AFDQ28067306-9758C12B-8B1D-45FF-80A6-4C95667B9360Q28397253-3A0CD7C5-CE73-45CF-B74D-9FFDC6CDCDB5Q28603589-ECEA9E90-1CF4-4B61-96F1-D36C9ECFAB81Q33265416-B29FD8DA-B764-48CE-849E-8E87D2E70134Q33425871-37241151-7306-42CD-A837-29E677059A54Q33503248-317CCCF0-65A0-47DC-BB29-8F9D1EE0EEA5Q33627062-A01BEBA3-A928-4798-A876-E6C50B204AB0Q33826578-7AD59828-6C79-4091-AF6A-495E7D776120Q33866931-42AC4A26-C5B2-4DD8-9457-1CE7016F7E50Q34945307-44446F8D-5428-45AC-B544-784C6F7CA778Q35039679-79E1B605-9D6E-4BBE-BC71-685B5FD2F889Q35227689-1762CBBA-23E3-474D-90AB-16F6345722B5Q35487824-73A39146-050C-4BE7-9D32-9A9052814357Q35790223-CFB84E2D-C441-40ED-B90E-1F3F98F086F2Q36078058-A93A895D-371D-45EC-AA6C-3D5F2151ABBFQ36313607-C09C3C90-69E5-4F9B-8D95-F5C13D65CD02Q36350080-EA2804C7-D860-467F-850B-0854E741CFA1Q36673887-5A116367-6FC1-4A4D-976F-664BB19EE963Q36736465-40E1CBB6-5751-4035-BD85-C478F2E08DA6Q36844861-5DE05AD5-14D4-4051-8356-91A678CB74FBQ36884501-8FFA5B38-B86E-49A0-AF08-FCA1A240119CQ37059927-D6652279-380E-4710-8B1E-11158D1D4441Q37144577-1A0FD3B1-035B-43D9-81F1-95A89802B1AFQ37273948-CDC06615-B6E2-4371-A7F6-9CAFCA1DC751Q37309538-0107404A-6532-4A85-BB05-54C653F489CEQ37668208-5F6EC8E1-90C9-4D8A-BBD0-7DDE9AB2084CQ37729535-582C9264-E942-4188-AEAF-7264F2D477D1Q37859621-8977467C-C947-4C4A-BF4A-63BFC2B02DD2Q37882523-1F4A68B9-6E42-4F0D-8947-2A459FEF564DQ38620366-20B77C23-2923-475C-B18F-635FD7FFC06DQ38742184-702E39FF-9390-4995-A8C7-F219DA58638BQ38833392-52AD090F-8DBB-40DD-8307-3FEE33518B63Q38899894-CB997022-BF5D-4E0A-87BA-A899A4908944Q40063744-A0F39003-9027-4593-B23C-5B4A0EF86101Q40146203-5C28D657-7A12-49D3-8ACE-8F5205163123Q41121016-A940C215-9429-49FC-99C1-50DAE55F7BE9Q41158665-69823D78-6CD7-4E51-8BAC-3D2E5CDB0639Q41161964-B845591A-3E47-4BC9-A3D3-DF932533AB88Q41596789-1AB62A41-BE1F-4F3B-A8C3-4F589C68DF87
P2860
Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Down-modulation of lung immune ...... and II in active tuberculosis.
@en
Down-modulation of lung immune ...... ransforming growth factor beta
@nl
type
label
Down-modulation of lung immune ...... and II in active tuberculosis.
@en
Down-modulation of lung immune ...... ransforming growth factor beta
@nl
prefLabel
Down-modulation of lung immune ...... and II in active tuberculosis.
@en
Down-modulation of lung immune ...... ransforming growth factor beta
@nl
P2093
P2860
P1476
Down-modulation of lung immune ...... and II in active tuberculosis
@en
P2093
Howard Doo
Jiayuan Geng
José R Lapa e Silva
Lorena Rego
Luiz Claudio Oliveira Lazzarini
M Glória Bonecini-Almeida
Neio Boéchat
Richard C Huard
Sadhana Chitale
P2860
P304
P356
10.1128/IAI.72.5.2628-2634.2004
P407
P577
2004-05-01T00:00:00Z